Drugs · acquisition-cost intelligence
hydromorphone hydrochloride
· ingredient hydromorphoneNatural opium alkaloids· HYDROMORPHONE HYDROCHLORIDE 12 mg/1; HYDROMORPHONE HYDROCHLORIDE 16 mg/1; HYDROMORPHONE HYDROCHLORIDE 32 mg/1; HYDROMORPHONE HYDROCHLORIDE 8 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$9.82
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 9 weeks.
2025-02-192026-05-20
Same-ingredient options by acquisition cost
Other hydromorphone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Dilaudid | $0.21765 | −$9.61 |
| hydromorphone hydrochloride | $0.21765 | −$9.61 |
| Hydromorphone Hydrochloride | $2.57 | −$7.26 |
| Hydromorphone Hydrochloride | $2.57 | −$7.26 |
| Hydromorphone Hydrochloride | $2.77 | −$7.06 |
Medicare Part D coverage · CY2026
On 26 plan formularies · typical tier 4
Prior auth 77% · Step therapy 0% · Quantity limit 89% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.